Description of Research Expertise:
Antibody and Cellular Mediated Heart Transplant Rejection
End-stage Heart Failure
Hepatitis C positive donors for HCV negative transplant recipients
Selected Publications:
Ahluwalia M, Jessup M, Forde KA, Sehgal S, Katz ST, Quiaoit YAA, Hornsby N, Owens AT, McLean RC.: Clinical utility of surveillance and clinically prompted right heart catheterization in patients listed for heart transplantation. Catheter Cardiovasc Interv : 2019.
Kim YY, Awh K, Acker M, Atluri P, Bermudez C, Crespo M, Diamond JM, Drajpuch D, Forde-Mclean R, Fuller S, Goldberg L, Mazurek J, Mascio C, Menachem JN, Rame E, Ruckdeschel E, Tobin L, Wald J.: Pulmonary arterial hypertension in adults with systemic right ventricles referred for cardiac transplantation. Clin Transplant. : 2019.
Ambardekar AV, Kittleson MM, Palardy M, Mountis MM, Forde-McLean RC, DeVore AD, Pamboukian SV, Thibodeau JT, Teuteberg JJ, Cadaret L, Xie R, Taddei-Peters W, Naftel DC, Kirklin JK, Stevenson LW, Stewart GC.: Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. J Heart Lung Transplant. : 2019.
McLean RC, Reese PP, Acker M, Atluri P, Bermudez C, Goldberg LR, Abt PL, Blumberg EA, Van Deerlin VM, Reddy KR, Bloom RD, Hasz R, Suplee L, Sicilia A, Woodards A, Zahid MN, Bar KJ, Porrett P, Levine MH, Hornsby N, Gentile C, Smith J, Goldberg DS.: Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial. Am J Transplant. : 2019.
Amrut V. Ambardekar, Michelle M. Kittleson, Maryse Palardy, Maria M. Mountis, Rhondalyn C. Forde-McLean, Adam D. DeVore, Salpy V. Pamboukian, Jennifer T. Thibodeau, Jeffrey J. Teuteberg, Linda Cadaret, Rongbing Xie, Wendy Taddei-Peters, David C. Naftel, James K. Kirklin, Lynne W. Stevenson, Garrick C. Stewart: Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry The Journal of Heart and Lung Transplantation : 2018.
Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S, Nielsen CD, van der Harst P, Hoendermis E, Penicka M, Bartunek J, Fail PS, Kaye DM, Walton A, Petrie MC, Walker N, Basuray A, Yakubov S, Hummel SL, Chetcuti S, Forde-McLean R, Herrmann HC, Burkhoff D, Massaro JM, Cleland JGF, Mauri L.: One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiology : 2018.
McLean R, Reese P, Acker M, Atluri P, Blumberg E, Reddy R, Hornsby N, Abt P, Sicilia A, Goldberg D: Early Results from the USHER Study: a Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Treatment. American Transplant Congress : 2018.
Rhoades D, Tabibian J, Forde K, McLean R, Chandrasekhara V: Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, presentation, and Management. Clin Gastroenterol Hepatol 17 (3): 448-454,2018.
Feldman T, Mauri L, Kahwash R, Litwin S, Ricciardi MJ, van der Harst P, Penicka M, Fail PS, Kaye DM, Petrie MC, Basuray A, Hummel SL, Forde-McLean R, Nielsen CD, Lilly S, Massaro JM, Burkhoff D, Shah SJ; REDUCE LAP-HF Investigators and Study Coordinators: Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]: A Phase 2, Randomized, Sham-Controlled Trial. Circulation 137 (4): 364-375,2018.
Kim Y, Wald J, Acker M, Atluri P, Fuller S, Mascio C, McLean R, Ruckdeschel E, Drajpuch D, Tobin L: Single Center Outcomes of Heart Transplantation Referrals in Adults with Systemic Right Ventricles ISHLT : 2018.